Using change in the National Institutes of Health stroke scale to measure treatment effect in acute stroke trials

Askiel Bruno, Chandan Sana, Linda S. Williams

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Background and Purpose - Outcome measures in acute stroke trials are being refined. Changes in neurological deficits might be useful outcome measures because they can measure the entire spectrum of deficits. Methods - We analyzed data from the acute stroke treatment trial Trial of Org 10172 in Acute Stroke Treatment (TOAST). Using logistic regression analysis, we modeled the probability of the TOAST predefined very favorable outcome (VFO; both Glasgow Outcome Scale 1 and modified Barthel Index 19 to 20) at 3 months. Within-subject changes (baseline-3 months) on the National Institutes of Health Stroke Scale (NIHSS) was the main predictor of interest. Results - The baseline median NIHSS for the entire TOAST cohort was 7, and it improved by 4 points (interquartile range 3 to 6) among 603 patient with VFO and by 2 points (interquartile range -1 to 5) among 638 patients without a VFO (P<0.001). The odds for VFO increased by 2.29 (95% CI, 2.06 to 2.54; P<0.001) for each 1-point improvement on the NIHSS. In receiver operating characteristic analysis, final NIHSS ≤2 was a good predictor of VFO, but no single NIHSS change cut point was a good predictor of VFO. Conclusions - NIHSS change appears to be a useful outcome measure for acute stroke trials and is not fully comparable to dichotomized functional outcomes.

Original languageEnglish (US)
Pages (from-to)920-921
Number of pages2
JournalStroke
Volume37
Issue number3
DOIs
StatePublished - Mar 1 2006

Fingerprint

National Institutes of Health (U.S.)
Stroke
Therapeutics
Outcome Assessment (Health Care)
Glasgow Outcome Scale
ROC Curve
Logistic Models
Regression Analysis

Keywords

  • Outcome
  • Recovery of function
  • Stroke, acute

ASJC Scopus subject areas

  • Clinical Neurology
  • Cardiology and Cardiovascular Medicine
  • Advanced and Specialized Nursing

Cite this

Using change in the National Institutes of Health stroke scale to measure treatment effect in acute stroke trials. / Bruno, Askiel; Sana, Chandan; Williams, Linda S.

In: Stroke, Vol. 37, No. 3, 01.03.2006, p. 920-921.

Research output: Contribution to journalArticle

@article{e01cd72dc6624869b781b76c087e845b,
title = "Using change in the National Institutes of Health stroke scale to measure treatment effect in acute stroke trials",
abstract = "Background and Purpose - Outcome measures in acute stroke trials are being refined. Changes in neurological deficits might be useful outcome measures because they can measure the entire spectrum of deficits. Methods - We analyzed data from the acute stroke treatment trial Trial of Org 10172 in Acute Stroke Treatment (TOAST). Using logistic regression analysis, we modeled the probability of the TOAST predefined very favorable outcome (VFO; both Glasgow Outcome Scale 1 and modified Barthel Index 19 to 20) at 3 months. Within-subject changes (baseline-3 months) on the National Institutes of Health Stroke Scale (NIHSS) was the main predictor of interest. Results - The baseline median NIHSS for the entire TOAST cohort was 7, and it improved by 4 points (interquartile range 3 to 6) among 603 patient with VFO and by 2 points (interquartile range -1 to 5) among 638 patients without a VFO (P<0.001). The odds for VFO increased by 2.29 (95{\%} CI, 2.06 to 2.54; P<0.001) for each 1-point improvement on the NIHSS. In receiver operating characteristic analysis, final NIHSS ≤2 was a good predictor of VFO, but no single NIHSS change cut point was a good predictor of VFO. Conclusions - NIHSS change appears to be a useful outcome measure for acute stroke trials and is not fully comparable to dichotomized functional outcomes.",
keywords = "Outcome, Recovery of function, Stroke, acute",
author = "Askiel Bruno and Chandan Sana and Williams, {Linda S.}",
year = "2006",
month = "3",
day = "1",
doi = "10.1161/01.STR.0000202679.88377.e4",
language = "English (US)",
volume = "37",
pages = "920--921",
journal = "Stroke",
issn = "0039-2499",
publisher = "Lippincott Williams and Wilkins",
number = "3",

}

TY - JOUR

T1 - Using change in the National Institutes of Health stroke scale to measure treatment effect in acute stroke trials

AU - Bruno, Askiel

AU - Sana, Chandan

AU - Williams, Linda S.

PY - 2006/3/1

Y1 - 2006/3/1

N2 - Background and Purpose - Outcome measures in acute stroke trials are being refined. Changes in neurological deficits might be useful outcome measures because they can measure the entire spectrum of deficits. Methods - We analyzed data from the acute stroke treatment trial Trial of Org 10172 in Acute Stroke Treatment (TOAST). Using logistic regression analysis, we modeled the probability of the TOAST predefined very favorable outcome (VFO; both Glasgow Outcome Scale 1 and modified Barthel Index 19 to 20) at 3 months. Within-subject changes (baseline-3 months) on the National Institutes of Health Stroke Scale (NIHSS) was the main predictor of interest. Results - The baseline median NIHSS for the entire TOAST cohort was 7, and it improved by 4 points (interquartile range 3 to 6) among 603 patient with VFO and by 2 points (interquartile range -1 to 5) among 638 patients without a VFO (P<0.001). The odds for VFO increased by 2.29 (95% CI, 2.06 to 2.54; P<0.001) for each 1-point improvement on the NIHSS. In receiver operating characteristic analysis, final NIHSS ≤2 was a good predictor of VFO, but no single NIHSS change cut point was a good predictor of VFO. Conclusions - NIHSS change appears to be a useful outcome measure for acute stroke trials and is not fully comparable to dichotomized functional outcomes.

AB - Background and Purpose - Outcome measures in acute stroke trials are being refined. Changes in neurological deficits might be useful outcome measures because they can measure the entire spectrum of deficits. Methods - We analyzed data from the acute stroke treatment trial Trial of Org 10172 in Acute Stroke Treatment (TOAST). Using logistic regression analysis, we modeled the probability of the TOAST predefined very favorable outcome (VFO; both Glasgow Outcome Scale 1 and modified Barthel Index 19 to 20) at 3 months. Within-subject changes (baseline-3 months) on the National Institutes of Health Stroke Scale (NIHSS) was the main predictor of interest. Results - The baseline median NIHSS for the entire TOAST cohort was 7, and it improved by 4 points (interquartile range 3 to 6) among 603 patient with VFO and by 2 points (interquartile range -1 to 5) among 638 patients without a VFO (P<0.001). The odds for VFO increased by 2.29 (95% CI, 2.06 to 2.54; P<0.001) for each 1-point improvement on the NIHSS. In receiver operating characteristic analysis, final NIHSS ≤2 was a good predictor of VFO, but no single NIHSS change cut point was a good predictor of VFO. Conclusions - NIHSS change appears to be a useful outcome measure for acute stroke trials and is not fully comparable to dichotomized functional outcomes.

KW - Outcome

KW - Recovery of function

KW - Stroke, acute

UR - http://www.scopus.com/inward/record.url?scp=33645056479&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33645056479&partnerID=8YFLogxK

U2 - 10.1161/01.STR.0000202679.88377.e4

DO - 10.1161/01.STR.0000202679.88377.e4

M3 - Article

C2 - 16439701

AN - SCOPUS:33645056479

VL - 37

SP - 920

EP - 921

JO - Stroke

JF - Stroke

SN - 0039-2499

IS - 3

ER -